Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "V08AB04" (27)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
Iopamidol (V08AB04) 27 products
WHO-DDD
DrugBank.ca
IP
Iopamiro 300
10 ml
7.86
17.80
10 %
Injection solution: Iopamidolum 612.4 mg/ml
Bracco Suisse SA
● 
B / SL
FB
G
IP
Iopamiro 300
50 ml
27.02
45.80
10 %
Injection solution: Iopamidolum 612.4 mg/ml
Bracco Suisse SA
B / SL
FB
G
IP
Iopamiro 300
100 ml
52.30
73.30
10 %
Injection solution: Iopamidolum 612.4 mg/ml
Bracco Suisse SA
B / SL
FB
G
IP
Iopamiro 300
200 ml
101.26
126.55
10 %
Injection solution: Iopamidolum 612.4 mg/ml
Bracco Suisse SA
B / SL
FB
G
IP
Iopamiro 370
50 ml
31.30
50.45
10 %
Injection solution: Iopamidolum 755.3 mg/ml
Bracco Suisse SA
B / SL
FB
G
IP
Iopamiro 370
100 ml
60.45
82.15
10 %
Injection solution: Iopamidolum 755.3 mg/ml
Bracco Suisse SA
B / SL
FB
G
IP
Iopamiro 370
200 ml
116.95
143.60
10 %
Injection solution: Iopamidolum 755.3 mg/ml
Bracco Suisse SA
B / SL
FB
G
L
IP
Iopamiro 370
500 ml
292.38
334.40
10 %
Injection solution: Iopamidolum 755.3 mg/ml
Bracco Suisse SA
B / SL
FB
G
IP
Iopamiro 150
100 ml
31.05
52.05
k.A.
Injection solution: Iopamidolum 306.2 mg/ml
Bracco Suisse SA
B
FB
G
IP
Iopamiro 300
30 ml
19.73
39.05
k.A.
Injection solution: Iopamidolum 612.4 mg/ml
Bracco Suisse SA
B
FB
G
IP
Iopamiro 300
500 ml
253.14
307.30
k.A.
Injection solution: Iopamidolum 612.4 mg/ml
Bracco Suisse SA
B
FB
G
IP
Scanlux 300 mg/ml
50 ml
PR
PR
k.A.
Injection solution: Iopamidolum 612 mg/ml
b.e.imaging.ag
B
FB
G
IP
Scanlux 300 mg/ml
100 ml
PR
PR
k.A.
Injection solution: Iopamidolum 612 mg/ml
b.e.imaging.ag
B
FB
G
IP
Scanlux 300 mg/ml
200 ml
PR
PR
k.A.
Injection solution: Iopamidolum 612 mg/ml
b.e.imaging.ag
B
FB
G
IP
Scanlux 300 mg/ml
10 x 50 ml
PR
PR
k.A.
Injection solution: Iopamidolum 612 mg/ml
b.e.imaging.ag
B
FB
G
IP
Scanlux 300 mg/ml
500 ml
PR
PR
k.A.
Injection solution: Iopamidolum 612 mg/ml
b.e.imaging.ag
B
FB
G
IP
Scanlux 300 mg/ml
10 x 100 ml
PR
PR
k.A.
Injection solution: Iopamidolum 612 mg/ml
b.e.imaging.ag
B
FB
G
IP
Scanlux 300 mg/ml
10 x 200 ml
PR
PR
k.A.
Injection solution: Iopamidolum 612 mg/ml
b.e.imaging.ag
B
FB
G
IP
Scanlux 300 mg/ml
5 x 500 ml
PR
PR
k.A.
Injection solution: Iopamidolum 612 mg/ml
b.e.imaging.ag
B
FB
G
IP
Scanlux 370 mg/ml
50 ml
PR
PR
k.A.
Injection solution: Iopamidolum 755 mg/ml
b.e.imaging.ag
B
FB
G
IP
Scanlux 370 mg/ml
100 ml
PR
PR
k.A.
Injection solution: Iopamidolum 755 mg/ml
b.e.imaging.ag
B
FB
G
IP
Scanlux 370 mg/ml
200 ml
PR
PR
k.A.
Injection solution: Iopamidolum 755 mg/ml
b.e.imaging.ag
B
FB
G
IP
Scanlux 370 mg/ml
10 x 50 ml
PR
PR
k.A.
Injection solution: Iopamidolum 755 mg/ml
b.e.imaging.ag
B
FB
G
IP
Scanlux 370 mg/ml
500 ml
PR
PR
k.A.
Injection solution: Iopamidolum 755 mg/ml
b.e.imaging.ag
B
FB
G
IP
Scanlux 370 mg/ml
10 x 100 ml
PR
PR
k.A.
Injection solution: Iopamidolum 755 mg/ml
b.e.imaging.ag
B
FB
G
IP
Scanlux 370 mg/ml
10 x 200 ml
PR
PR
k.A.
Injection solution: Iopamidolum 755 mg/ml
b.e.imaging.ag
B
FB
G
IP
Scanlux 370 mg/ml
5 x 500 ml
PR
PR
k.A.
Injection solution: Iopamidolum 755 mg/ml
b.e.imaging.ag
B
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home